Where can I get compounded Compounded Tirzepatide 11 mg (Sublingual)?

Compounded Tirzepatide 11 mg (Sublingual) is available at compounding pharmacies on the SlimionRX network, including Benbrook pharmacy .

Compounded Tirzepatide 11 mg (Sublingual) 11.43 mg / 0.5 mL — Compounded Sublingual Liquid Patient Monograph

Patient education monograph for Compounded Tirzepatide 11 mg (Sublingual) (11.43 mg / 0.5 mL), a compounded sublingual liquid. Learn how it works, how to use it, possible side effects, and find a licensed compounding pharmacy near you.

What is Compounded Tirzepatide 11 mg (Sublingual)?

This compounded preparation contains tirzepatide 11.43 mg per 0.5 mL in a sublingual liquid base, prepared by a licensed compounding pharmacy pursuant to a valid individual patient prescription. It is intended for patients who have completed initial tirzepatide titration and are advancing toward higher maintenance doses within a medically supervised weight management program. Compounded tirzepatide is not an FDA-approved product. Formula developed in partnership with Richie's Specialty Pharmacy.

How does Compounded Tirzepatide 11 mg (Sublingual) work?

Tirzepatide is a dual agonist at both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors. GIP receptor activation enhances insulin secretion, reduces glucagon release, and may directly affect adipose tissue lipid metabolism. GLP-1 receptor activation suppresses appetite, slows gastric emptying, and promotes satiety. The combined dual-receptor action of tirzepatide produces synergistic effects on weight reduction and glycemic control that exceed those seen with single GLP-1 receptor agonists. At 11.43 mg, this dose is appropriate for patients advancing through titration.

How to use Compounded Tirzepatide 11 mg (Sublingual)

Administer under the tongue as directed by your prescriber, typically once weekly. Hold the preparation under the tongue for at least 60 seconds before swallowing. Do not eat, drink, or rinse your mouth for at least 10 minutes after administration. Administer on the same day each week. Do not increase the dose without prescriber guidance.

Compounded Tirzepatide 11 mg (Sublingual) side effects

Nausea, vomiting, diarrhea, constipation, and abdominal pain are the most commonly reported effects — typically most pronounced during dose escalation and improving with continued therapy. Decreased appetite is expected and intended. Fatigue and dizziness may occur. At this higher dose range, GI effects may be more noticeable. Report severe abdominal pain, persistent vomiting, tachycardia, or signs of dehydration to your prescriber immediately.

Drug interactions with Compounded Tirzepatide 11 mg (Sublingual)

Tirzepatide slows gastric emptying and may reduce absorption of concurrently taken oral medications. Concurrent insulin and sulfonylurea use increases hypoglycemia risk — dose adjustment may be required. Disclose all medications, supplements, and OTC products to your prescriber before starting. Use caution with medications that have narrow therapeutic windows and require consistent oral absorption.

How to store Compounded Tirzepatide 11 mg (Sublingual)

Refrigerate at 36°F–46°F (2°C–8°C). Do not freeze. Protect from light. Keep tightly closed. Use within the beyond-use date printed on the pharmacy label. Discard if the solution appears cloudy, discolored, or contains visible particles.

Precautions for Compounded Tirzepatide 11 mg (Sublingual)

Contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Use only under active prescriber supervision. At this dose level, GI side effects and potential for gallbladder issues are more relevant — attend all monitoring appointments. Keep out of reach of children.

Where to get compounded Compounded Tirzepatide 11 mg (Sublingual)

Compounded Tirzepatide 11 mg (Sublingual) is available through licensed compounding pharmacies on the SlimionRX network:

Benbrook pharmacy — Benbrook, TX

Frequently Asked Questions — Compounded Tirzepatide 11 mg (Sublingual)

What is Compounded Tirzepatide 11 mg (Sublingual)?: This compounded preparation contains tirzepatide 11.43 mg per 0.5 mL in a sublingual liquid base, prepared by a licensed compounding pharmacy pursuant to a valid individual patient prescription. It is intended for patients who have completed initial tirzepatide titration and are advancing toward higher maintenance doses within a medically supervised weight management program. Compounded tirzepatide is not an FDA-approved product. Formula developed in partnership with Richie's Specialty Pharmacy.
How does Compounded Tirzepatide 11 mg (Sublingual) work?: Tirzepatide is a dual agonist at both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors. GIP receptor activation enhances insulin secretion, reduces glucagon release, and may directly affect adipose tissue lipid metabolism. GLP-1 receptor activation suppresses appetite, slows gastric emptying, and promotes satiety. The combined dual-receptor action of tirzepatide produces synergistic effects on weight reduction and glycemic control that exceed those seen with single GLP-1 re
How do I use Compounded Tirzepatide 11 mg (Sublingual)?: Administer under the tongue as directed by your prescriber, typically once weekly. Hold the preparation under the tongue for at least 60 seconds before swallowing. Do not eat, drink, or rinse your mouth for at least 10 minutes after administration. Administer on the same day each week. Do not increase the dose without prescriber guidance.
What are the side effects of Compounded Tirzepatide 11 mg (Sublingual)?: Nausea, vomiting, diarrhea, constipation, and abdominal pain are the most commonly reported effects — typically most pronounced during dose escalation and improving with continued therapy. Decreased appetite is expected and intended. Fatigue and dizziness may occur. At this higher dose range, GI effects may be more noticeable. Report severe abdominal pain, persistent vomiting, tachycardia, or signs of dehydration to your prescriber immediately.
Are there drug interactions with Compounded Tirzepatide 11 mg (Sublingual)?: Tirzepatide slows gastric emptying and may reduce absorption of concurrently taken oral medications. Concurrent insulin and sulfonylurea use increases hypoglycemia risk — dose adjustment may be required. Disclose all medications, supplements, and OTC products to your prescriber before starting. Use caution with medications that have narrow therapeutic windows and require consistent oral absorption.
How should I store Compounded Tirzepatide 11 mg (Sublingual)?: Refrigerate at 36°F–46°F (2°C–8°C). Do not freeze. Protect from light. Keep tightly closed. Use within the beyond-use date printed on the pharmacy label. Discard if the solution appears cloudy, discolored, or contains visible particles.
What precautions should I know about Compounded Tirzepatide 11 mg (Sublingual)?: Contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Use only under active prescriber supervision. At this dose level, GI side effects and potential for gallbladder issues are more relevant — attend all monitoring appointments. Keep out of reach of children.
Where can I get compounded Compounded Tirzepatide 11 mg (Sublingual)?: Compounded Tirzepatide 11 mg (Sublingual) is available at compounding pharmacies on the SlimionRX network, including Benbrook pharmacy .